ArticleJournal of cellular and molecular medicine2024

SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death.

Jooyoung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.